SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-003005
Filing Date
2020-12-21
Accepted
2020-12-21 18:36:55
Documents
2
Period of Report
2020-12-17

Document Format Files

Seq Description Document Type Size
1 form4-12212020_031245.html 4  
1 form4-12212020_031245.xml 4 3770
2 ex24-12212020_031245.htm EX-24 15928
  Complete submission text file 0001415889-20-003005.txt   21203
Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 5445 DTC PARKWAY, SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address
MACALUSO MICHAEL (Reporting) CIK: 0001096423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 201405566

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations